Purchase Order HHSN302201700084P

This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a civilian agency within the U.S. Department of Health and Human Services, to Quest Diagnostics Nichols Institute Inc., a subsidiary of Quest Diagnostics Incorporated. The contract, valued at $24,596.20, is for cytogenetics testing services to support patients enrolled in NHGRI clinical protocols at the Clinical Center. The contract has an ultimate completion date of July 16, 2026. This...

Quest Diagnostics Nichols Institute Inc., doing business as Quest Diagnostics, has been awarded a firm fixed price purchase order contract valued at sixteen thousand dollars by the Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute. The contract is for cytogenetics testing services to be delivered between February 1, 2024 and September 30, 2024 in Chantilly, Virginia. No set-aside designation was applied to this procurement. Quest...

<p>The National Human Genome Research Institute awarded a purchase order to Georgetown University for $19,999.00 on December 18, 2019, for generic testing. Performance takes place in Bethesda, Maryland. The firm fixed-price order was completed on the award date. No small business set-aside applied.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Qiagen, LLC for $10,456.60 on August 16, 2016, with firm fixed price, no set-aside. Place of performance is Bethesda, Maryland. The order calls for molecular diagnostics consumables and reagents, including DNA/RNA extraction kits and related laboratory supplies. Ultimate completion date is December 22, 2020.</p>

<p>The National Human Genome Research Institute issued a purchase order to Qiagen, LLC on August 17, 2016, for $4,285.40 under a firm fixed-price arrangement. Performance is located in Bethesda, Maryland, with an ultimate completion date of December 23, 2020. No set-aside was applied to this order. The source does not specify the particular products or services procured under this purchase order.</p>

<p>The National Human Genome Research Institute issued a purchase order to Medical Neurogenetics, LLC on February 6, 2018, for clinical genetic testing with a ceiling value of $249,481.00. Work is performed in Bethesda, Maryland. The order was completed by November 2, 2023. Pricing is firm fixed price with no small business set-aside applied.</p>

<p>The National Human Genome Research Institute issued a $149,618.50 delivery order to Illumina, Inc., on September 1, 2017, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is North Bethesda, MD. The order has a firm fixed-price structure with an ultimate completion date of September 30, 2017.</p>

The Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development awarded a $22,392 delivery order contract to Quest Diagnostics Incorporated for genomic hybridization array testing services. Quest Diagnostics will perform the testing under its Medical Laboratory Testing and Analysis Services contract schedule with the General Services Administration. The contract has a period of performance from September 2015 through September...

The National Human Genome Research Institute issued a $12,028 delivery order to Beckman Coulter, Inc. on December 18, 2018, under a single-award Indefinite Delivery Contract with the Office of Logistics and Acquisition Operations for biomedical laboratory equipment, reagents, software, maintenance, and related services. Place of performance is Bethesda, MD. The order carried an ultimate completion date of September 30, 2019. Pricing was firm fixed price with no set-aside designation.

<p>The National Human Genome Research Institute issued a $122,145.01 delivery order to Illumina, Inc. on September 15, 2017, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD 20892. The order has a firm fixed-price structure with an ultimate completion date of December 15, 2017. No set-aside was used.</p>